Artikel: How do tumor cells respond to HDAC inhibition?
FEBS journal. 2016 Nov., v. 283, no. 22
2016
Abstract: It is now well recognized that mutations, deregulated expression, and aberrant recruitment of epigenetic readers, writers, and erasers are fundamentally important processes in the onset and maintenance of many human tumors. The molecular, biological, and ...
Abstract | It is now well recognized that mutations, deregulated expression, and aberrant recruitment of epigenetic readers, writers, and erasers are fundamentally important processes in the onset and maintenance of many human tumors. The molecular, biological, and biochemical characteristics of a particular class of epigenetic erasers, the histone deacetylases (HDACs), have been extensively studied and smallâmolecule HDAC inhibitors (HDACis) have now been clinically approved for the treatment of human hemopoietic malignancies. This review explores our current understanding of the biological and molecular effects on tumor cells following HDACi treatment. The predominant responses include induction of tumor cell death and inhibition of proliferation that in experimental models have been linked to therapeutic efficacy. However, tumor cellâintrinsic responses to HDACi, including modulating tumor immunogenicity have also been described and may have substantial roles in mediating the antitumor effects of HDACi. We posit that the field has failed to fully reconcile the biological consequences of exposure to HDACis with the molecular events that underpin these responses, however progress is being made. Understanding the pleiotrophic activities of HDACis on tumor cells will hopefully fast track the development of more potent and selective HDACi that may be used alone or in combination to improve patient outcomes. |
---|---|
Schlagwörter | antineoplastic activity ; cell death ; epigenetics ; histone deacetylase ; humans ; immune response ; models ; mutation ; neoplasm cells ; neoplasms ; patients |
Sprache | Englisch |
Erscheinungsverlauf | 2016-11 |
Umfang | p. 4032-4046. |
Erscheinungsort | John Wiley & Sons, Ltd |
Dokumenttyp | Artikel |
Anmerkung | REVIEW |
ZDB-ID | 2173655-8 |
ISSN | 1742-4658 ; 1742-464X |
ISSN (online) | 1742-4658 |
ISSN | 1742-464X |
DOI | 10.1111/febs.13746 |
Datenquelle | NAL Katalog (AGRICOLA) |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Bonn
Z 2006/704: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.
Fernleihe an ZB MED
Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.